Cargando…

Emergency-department initiated buprenorphine: Impact on quality of life

INTRODUCTION: Emergency department (ED)-initiated medications for opioid use disorder (MOUD) have emerged as an acute care strategy against the opioid epidemic. When initiated in the outpatient setting, MOUD has been demonstrated to have a positive impact on patients’ quality of life (QoL). It is un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carroll, Caleb, Hand, Delissa, Covington, Whitney, Rodgers, Joel, Hudson, Jolanda, Li, Li, Walter, Lauren A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Full Length Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522937/ https://www.ncbi.nlm.nih.gov/pubmed/37771948 http://dx.doi.org/10.1016/j.dadr.2023.100191

Ejemplares similares

Advancing emergency department–initiated buprenorphine
por: Huntley, Kristen, et al.
Publicado: (2021)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

The introduction of a novel formulation of buprenorphine into organized health systems()()
por: Mullen, William, et al.
Publicado: (2022)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use
por: Winstanley, Erin L., et al.
Publicado: (2022)

State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
por: Silwal, Anita, et al.
Publicado: (2023)

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
por: McFadden, Lisa M.
Publicado: (2023)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
por: Hawk, Kathryn F., et al.
Publicado: (2020)

Emergency department‐initiated buprenorphine protocols: A national evaluation
por: Guo, Clara Z., et al.
Publicado: (2021)

Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions
por: Kelly, Timothy D., et al.
Publicado: (2022)

Impact of COVID-19-related regulatory changes on nationwide access to buprenorphine: An interrupted time series design
por: Roy, Payel Jhoom, et al.
Publicado: (2023)

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims
por: Xu, Kevin Y, et al.
Publicado: (2023)

Receipt and duration of buprenorphine treatment during pregnancy and postpartum periods in a national privately-insured cohort
por: Wang, Xi, et al.
Publicado: (2023)

Co-designing and piloting educational materials with patients and healthcare providers for syncope in the emergency department
por: McMullen, Colleen A., et al.
Publicado: (2023)

Impact of reduced restrictions on buprenorphine prescribing during COVID-19 among patients in a community-based treatment program
por: Ward, Kathleen M., et al.
Publicado: (2022)

Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021
por: del Pozo, Brandon, et al.
Publicado: (2023)

Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency
por: Pizzi, Roberto, et al.
Publicado: (2020)

Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data
por: John, William S., et al.
Publicado: (2022)

Sex specific effects of buprenorphine on behavior, astrocytic opioid receptor expression and neuroinflammation after pediatric traumatic brain injury in mice
por: Hamood, Yesmine, et al.
Publicado: (2022)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
por: Golan, Olivia K., et al.
Publicado: (2023)

Emergency physician perspectives on initiating buprenorphine/naloxone in the emergency department: A qualitative study
por: Dong, Kathryn A., et al.
Publicado: (2021)

Factors related to substance use treatment attendance after peer recovery coach intervention in the emergency department
por: Ware, Orrin D., et al.
Publicado: (2022)

Assessing the feasibility, usability and acceptability of the MySafeRx platform among individuals in outpatient buprenorphine treatment: Lessons learned from a pilot randomized controlled trial
por: Janzow, Grace E., et al.
Publicado: (2022)

An observational study on the use of long acting buprenorphine (Sublocade) and a Tamper resistant PICC for Outpatient IV antibiotic administration in Patients with serious infections and Opioid Use Disorder; The STOP OUD project
por: Pineo, Thomas, et al.
Publicado: (2021)

Implementing a Novel Statewide Network to Support Emergency Department-initiated Buprenorphine Treatment
por: Clemency, Brian M., et al.
Publicado: (2022)

An online acceptance, commitment, and self-compassion based treatment to decrease psychological distress in people with type 2 diabetes: A feasibility randomised-controlled trial
por: Kılıç, Ayşenur, et al.
Publicado: (2023)

Clinical decision support for tobacco screening and counseling parents of pediatric patients: A qualitative analysis of pediatric emergency department and urgent care professionals
por: Merianos, Ashley L., et al.
Publicado: (2021)

Odontoblast processes of the mouse incisor are plates oriented in the direction of growth
por: Shuhaibar, Ninna, et al.
Publicado: (2020)

Implementation of emergency department–initiated buprenorphine for opioid use disorder in a rural southern state
por: Bogan, Carolyn, et al.
Publicado: (2020)

High-Dose Buprenorphine Initiation in the Emergency Department Among Patients Using Fentanyl and Other Opioids
por: Snyder, Hannah, et al.
Publicado: (2023)

Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington
por: Fockele, Callan Elswick, et al.
Publicado: (2021)

Clinical and radiographic outcomes of extreme lateral approach to interbody fusion with β-tricalcium phosphate and hydroxyapatite composite for lumbar degenerative conditions
por: Rodgers, W. Blake, et al.
Publicado: (2012)

Emergency Department Clinicians’ Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study
por: Im, Dana D., et al.
Publicado: (2020)

Evaluation of an Albumin-Binding Domain Protein Fused to Recombinant Human IL-2 and Its Effects on the Bioactivity and Serum Half-Life of the Cytokine
por: Adabi, Elham, et al.
Publicado: (2017)

Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017
por: Rhee, Taeho Greg, et al.
Publicado: (2020)

Early divergence of translation initiation and elongation factors
por: Fer, Evrim, et al.
Publicado: (2022)

The relationship between patient satisfaction and visual and optical outcome after bilateral implantation of an extended depth of focus multifocal intraocular lens
por: Miháltz, Kata, et al.
Publicado: (2022)

FKBP5 and early life stress affect the hippocampus by an age-dependent mechanism
por: Criado-Marrero, Marangelie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7qgoqh864gjnro55dvffckjbku